Technology Transfer and Exclusive License Agreement Sample Contracts

TECHNOLOGY TRANSFER AND EXCLUSIVE LICENSE AGREEMENT between Arbutus Biopharma Corporation and Qilu Pharmaceutical Co., Ltd. December 13, 2021

Technology Transfer and Exclusive License Agreement • March 3rd, 2022 • Arbutus Biopharma Corp • Pharmaceutical preparations • Delaware

• Contract Type
  Technology Transfer and Exclusive License Agreement
• Filed
  March 3rd, 2022
• Company
  Arbutus Biopharma Corp
• Industry
  Pharmaceutical preparations
• Jurisdiction
  Delaware

This Technology Transfer and Exclusive License Agreement (this “Agreement”) is made as of December 13, 2021 (the “Execution Date”), by and between Arbutus Biopharma Corporation, a British Columbia corporation (“Arbutus”), having a place of business at 701 Veterans Circle, Warminster, PA 18974, USA, and Qilu Pharmaceutical Co., Ltd., a company established pursuant to applicable laws and regulations of the People’s Republic of China (“Qilu”), having a place of business at No. 8888 Lvyou Road, Jinan, Shandong 250104 China. Arbutus and Qilu are referred to in this Agreement individually as a “Party” and collectively as the “Parties.”